EcoDrugPlus

Endothelin Receptor Type B

Ensembl ID : ENSKMAG00000008303
Gene Symbol: EDNRB
3 Cross references
195 Possible Orthologues:

Endothelin-1 Receptor-Like

Ensembl ID : ENSKMAG00000004482
Gene Symbol: LOC108249163
3 Cross references
197 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSKMAG00000017786
Gene Symbol: EZH2
3 Cross references
229 Possible Orthologues:

Ephrin Type-B Receptor 4

Ensembl ID : ENSKMAG00000007242
Gene Symbol: LOC108250472
3 Cross references
167 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSKMAG00000003098
Gene Symbol: EGFR
3 Cross references
212 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSKMAG00000005060
Gene Symbol: EPHX2
3 Cross references
203 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSKMAG00000019542
Gene Symbol: ERBB3
3 Cross references
211 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSKMAG00000003490
Gene Symbol: ERBB4
3 Cross references
230 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSKMAG00000009365
Gene Symbol: ESR1
3 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSKMAG00000019451
Gene Symbol: LOC108249620
3 Cross references
208 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSKMAG00000022169
Gene Symbol: LOC108233438
3 Cross references
198 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSKMAG00000019101
Gene Symbol: ESRRG
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).